Alcalá PD, Siordia ZSP

Idioma: Español
Referencias bibliográficas: 22
Paginas: 143-147
Archivo PDF: 98.96 Kb.

RESUMEN

La alopecia androgenética es la forma de calvicie más frecuente. Se observa pérdida progresiva de pelos terminales, los cuales son reemplazados por pelos o vellos finos casi invisibles en respuesta a la circulación de andrógenos. Particularmente afecta a hombres, aunque también se observa en mujeres genéticamente predispuestas. En las mujeres el adelgazamiento puede ser difuso, pero es generalmente mayor en la región fronto-parietal con la línea de implantación frontal característicamente conservada. La pérdida de pelo es experimentada por hombres y mujeres como un evento perjudicial de grandes consecuencias personales y sociales que afecta de forma importante su calidad de vida.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Dunitz M, Randall V. The biology of androgenetic alopecia. Hair and its disorders. United King 2000: 123-136.

2. Norwood O. Incidence of female androgenetic alopecia (female patron alopecia). Dermatol Surg 2001; 27(1): 51-52.

3. Whiting D. Possible mechanism of miniaturization during androgenetic alopecia or pattern hair loss. J Am Acad Dermatol 2001; 45(3): S81-S86.

4. Sprecher E, Shalata A, Dabhah K et al. Androgenetic alopecia in heterozygous carriers of a mutation in the human hairless gene. J Am Acad Dermatol 2000; 42(6): 978-982.

5. Mahé Y, Michelet J, Billoni N et al. Androgenetic alopecia and microinflammation. Int J Dermatol 2000; 39: 576-584.

6. Bayne E, Flanagan J, Einstein M et al. Immunohistochemical localization of types 1 and 2 of 5 alfa reductase in human scalp. Br J Dermatol 1999; 141: 481-491.

7. Thiboutot D, Knaggs H, Gilliland K et al. Activity of type 1 of 5 alfa reductase is greater in the follicular infrainfundibulum compared with the epidermis. Br J Dermatol 1997; 136: 166-171.

8. Venning V, Dawber R. Patterned androgenetic alopecia in women. J Am Acad Dermatol 1988; 18(5): 1073-1077.

9. Olsen E. The midline part: An important physical clue to the clinical diagnosis of androgenetic alopecia in women. J Am Acad Dermatol 1999; 40(1): 106-109.

10. Ludwig E. Classification of types of androgenetic alopecia (commin baldness) ocurring in the female sex. Br J Dermatol 1977; 97: 247-254.

11. Kivanç I, Savas C, Godkdemir G et al. The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia. Int J Dermatol 2003; 42: 691-693.

12. Weedon D. Alopecia androgenética. Piel Patología. España 2002: 406-407.

13. Olsen E. Female pattern hair loss. J Am Acad Dermatol 2001; 45(3): S70-S80.

14. Price V, Roberts J, Hordinsky M et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad 2000; 43: 768-776.

15. Shum K, Messenger. Hair loss in women with hyperandrogenism: Four cases responding to finasteride. J Am Acad Dermatol 2002; 47: 733-739.

16. Khandpur S, Suman M, Reddy B. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. J Dermatol 2002; 29: 489-498.

17. Unger W, Unger R. Hair transplantin: An important but often forgotten treatment for female pattern hair loss. J Am Acad 2003; 49: 853-860.

18. Cash T. The psychosocial consequences of androgenetic alopecia: a review of research literature. Br J Dermatol 1999; 141: 398-405.

19. Cash T. Psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 1992; 26: 926-931.

20. Lee H, Ha S, Kim D et al. Perception of men with androgenetic alopecia by women and nonbalding men in Korea: How the nonbald regard the bald. Int J Dermatol 2002; 41: 867-869.

21. Van der Donk J, Meulenberg D, Stolz E et al. Psychologic characteristics of men with androgenetic alopecia and their modification. Int J Dermatol 1991; 30(1): 22-28.

22. Maffei C, Fossati A, Rinaldi F et al. Personality disorders and psychopathologic symptoms in patients with androgenetic alopecia. Arch Dermatol 1994; 130: 868-872.